See also this year's filing and all EDGAR filings for this company.
PDF Report 0001503802_2019_Karyopharm_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001503802, Karyopharm Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 334,612,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,863,000 |
| 3 | remainder_Assets | 2,717,000 |
| 4 | LiabilitiesCurrent | 46,904,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 111,118,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 48,847,000 |
| 9 | ResearchAndDevelopmentExpense | 161,372,000 |
| 10 | remainder_Expenses | 26,000 |
| 11 | remainder_Revenues | 30,336,000 |
| 12 | remainder_NetIncome | 1,502,000 |
| 13 | remainder_ComprehensiveNetIncome | -27,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 341,192,000 |
| 1 | Liabilities | 158,022,000 |
| 2 | Expenses | 210,245,000 |
| 3 | Revenues | 30,336,000 |
| 4 | StockholdersEquity | 183,170,000 |
| 5 | NetIncome | -178,407,000 |
| 6 | ComprehensiveNetIncome | -178,420,500 |
| 7 | BaseVar | 370,662,000 |
| 8 | EconomicCapitalRatio | 0.547 |
Edgar->Model Mapping
Feature Distribution
Change over Time
